2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow NNC126-0083: new trials by email Literature Review of NNC126-0083 trials Research Report on NNC126-0083
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 NNC126-0083, placebo - Growth Hormone Disorder, Healthy | Phase 1 | Completed | Novo Nordisk A/S | 40 | 2008-07-01 | 2017-02-08 |
| Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx® NNC126-0083, Norditropin® SimpleXx®, placebo - Growth Hormone Disorder, Healthy | Phase 1 | Completed | Novo Nordisk A/S | 56 | 2007-08-01 | 2017-02-09 |
Novo Nordisk A/S (2)
Denmark (1) · Germany (1)
2008 (1)